Emergency Contraception in Uruguay

March 2013 | 20 pages | ID: E93664EF93AEN
Euromonitor International Ltd

Abstracts

Its approval delayed several times, the law of Voluntary Interruption of Pregnancy was approved by the Uruguayan Legislative Power and with the necessary regulatory decrees, which began to be applied as of December 1, 2012. Anti-abortion lobbying, the Catholic Church and several members of the opposition however continue to oppose the law and are calling for a referendum to repeal the law. Among those opposing the law is former president Dr Tabaré Vázquez, who had vetoed the articles relating...

Euromonitor International's Emergency Contraception in Uruguay report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2008-2012, allowing you to identify the sectors driving growth. Forecasts to 2017 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Emergency Contraception market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

Headlines
Trends
Competitive Landscape
Prospects
Category Data
  Table 1 Sales of Emergency Contraception: Value 2007-2012
  Table 2 Sales of Emergency Contraception: % Value Growth 2007-2012
  Table 3 Emergency Contraception Company Shares 2008-2012
  Table 4 Emergency Contraception Brand Shares 2009-2012
  Table 5 Forecast Sales of Emergency Contraception: Value 2012-2017
  Table 6 Forecast Sales of Emergency Contraception: % Value Growth 2012-2017
Laboratorio Libra SA in Consumer Health (uruguay)
Strategic Direction
Key Facts
Summary 1 Laboratorio Libra SA: Key Facts
Company Background
Production
Competitive Positioning
Summary 2 Laboratorio Libra SA: Competitive Position 2012
Executive Summary
Value Sales Improve the Pace
Abortion Decriminalised in 2012
Double-digit Shares Remain Out of Reach
No Changes in Distribution
Sustained Growth Rates in the Future
Key Trends and Developments
Economic Growth Begins To Slow Down
A Small and Ageing Population
Obesity and Overweight on the Rise
Merging of Small Neighbourhood Pharmacies, A Key To Survival
Market Indicators
  Table 7 Consumer Expenditure on Health Goods and Medical Services 2007-2012
  Table 8 Life Expectancy at Birth 2007-2012
Market Data
  Table 9 Sales of Consumer Health by Category: Value 2007-2012
  Table 10 Sales of Consumer Health by Category: % Value Growth 2007-2012
  Table 11 Consumer Health Company Shares 2008-2012
  Table 12 Consumer Health Brand Shares 2009-2012
  Table 13 Sales of Consumer Health by Distribution Format: % Analysis 2007-2012
  Table 14 Sales of Consumer Health by Category and Distribution Format: % Analysis 2012
  Table 15 Forecast Sales of Consumer Health by Category: Value 2012-2017
  Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2012-2017
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Definitions
Sources
Summary 3 Research Sources